Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/01/2873258/0/en/SELLAS-Announces-Positive-Phase-2-Preliminary-Data-of-SLS009-in-r-r-AML-Achieving-a-100-Response-Rate-in-Patients-with-ASXL1-Mutation-At-the-Optimal-Dose-Level.html
https://www.globenewswire.com/news-release/2024/04/29/2871255/0/en/SELLAS-Life-Sciences-Announces-Positive-Recommendation-of-Independent-Data-Monitoring-Committee-Following-Completion-of-Enrollment-in-REGAL-Phase-3-Study.html
https://www.globenewswire.com/news-release/2024/03/28/2854454/0/en/SELLAS-Life-Sciences-Reports-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/03/26/2852262/0/en/SELLAS-Announces-Positive-Topline-Data-from-the-Phase-2a-Study-of-SLS009-in-r-r-AML-and-Provides-Steering-Committee-Update-on-Phase-3-REGAL-Study.html
https://www.globenewswire.com/news-release/2024/03/19/2848962/0/en/SELLAS-Life-Sciences-Group-Announces-Closing-of-20-Million-Registered-Direct-Offering-and-Concurrent-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/03/19/2848584/0/en/SELLAS-Life-Sciences-to-Host-Corporate-Update-Call-on-March-26-2024-at-8-15-am-ET.html
https://www.globenewswire.com//news-release/2024/03/15/2847066/0/en/SELLAS-Life-Sciences-Group-Announces-20-Million-Registered-Direct-Offering-and-Concurrent-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/03/08/2843075/0/en/SELLAS-Announces-Executive-Leadership-Reorganization-and-Prioritization-of-Commercialization-Partnerships.html
https://www.globenewswire.com//news-release/2024/03/01/2838804/0/en/SELLAS-Life-Sciences-Delivers-Oral-Presentation-of-SLS009-Phase-1-Data-for-Acute-Myeloid-Leukemia-Patients-at-2024-European-School-of-Haematology-ESH-Conference.html
https://www.globenewswire.com//news-release/2024/02/29/2837938/0/en/SELLAS-Life-Sciences-to-Present-SLS009-Phase-1-Data-from-Acute-Myeloid-Leukemia-Patients-at-the-2024-European-School-of-Haematology-ESH-Conference-Updated-Date-and-Time.html